The SARS‐CoV‐2 main protease (M <sup>pro</sup> ): Structure, function, and emerging therapies for COVID‐19-Reference-Cited by-同舟云学术

The SARS‐CoV‐2 main protease (M ^pro ): Structure, function, and emerging therapies for COVID‐19

Published:2022-07-14 Issue:3 Volume:3 Page:
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Hu Qing¹²,Xiong Yuan¹,Zhu Guang‐Hao¹,Zhang Ya‐Ni¹,Zhang Yi‐Wen²,Huang Ping²,Ge Guang‐Bo¹

Affiliation:

1. Shanghai Frontiers Science Center of TCM Chemical Biology Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditional Chinese Medicine Shanghai China

2. Clinical Pharmacy Center Cancer Center Department of Pharmacy Zhejiang Provincial People's Hospital Affiliated People's Hospital Hangzhou Medical College, Hangzhou Zhejiang China

Funder

Chinese Medicine Research Program of Zhejiang Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.151

Reference325 articles.

1. Molecular biology of coronaviruses: current knowledge

2. Nidovirales: Evolving the largest RNA virus genome